Brief: Yichang Hec Changjiang Pharmaceutical Sees Net Profit Attributable For Year
12/03/2024 15:29
March 12 (Reuters) - YiChang HEC ChangJiang
Pharmaceutical Co Ltd 1558.HK :
* SEES NET PROFIT ATTRIBUTABLE BETWEEN RMB1,900 MILLION AND
RMB2,100 MILLION FOR YEAR
* SEES REVENUE OF RMB6,295 MILLION FOR FY
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million